Pauline Laly Selected Research

Pauline Laly Research Topics

5	Melanoma (Melanoma, Malignant) 02/2022 - 10/2017
2	Myositis (Idiopathic Inflammatory Myopathies) 02/2019 - 01/2018
2	Edema (Dropsy) 02/2019 - 10/2017
2	Pain (Aches) 12/2018 - 10/2017
2	Neoplasms (Cancer) 01/2018 - 12/2017
1	Meckel Diverticulum 02/2022
1	Colitis 02/2022
1	Enteritis 02/2022
1	Enterocolitis 02/2022
1	Shock 02/2022
1	Hemorrhage 02/2022
1	Basal Cell Carcinoma (Rodent Ulcer) 01/2022
1	Keratoacanthoma 06/2019
1	Colorectal Neoplasms (Colorectal Cancer) 02/2019
1	Microsatellite Instability 02/2019
1	Necrosis 02/2019
1	Metabolic Bone Diseases (Osteopenia) 12/2018
1	Osteoporosis 12/2018
1	Myocarditis (Carditis) 01/2018
1	Pituitary Neoplasms (Pituitary Adenoma) 12/2017
1	Cushing Syndrome 12/2017
1	Hyperplasia 12/2017
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 11/2017
1	Muscle Hypotonia (Hypotonia) 10/2017
1	Fatigue 10/2017
1	Synovitis 10/2017
1	Muscular Diseases (Myopathy) 10/2017
1	Dropped Head Syndrome 10/2017
1	Primary Cutaneous Anaplastic Large Cell Lymphoma 09/2015

5	NivolumabIBA 02/2022 - 10/2017
5	Immune Checkpoint InhibitorsIBA 01/2018 - 10/2017
3	IpilimumabIBA 02/2022 - 01/2018
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 12/2018 - 10/2017
1	Infliximab (Remicade)FDA Link 02/2022
1	Adrenal Cortex Hormones (Corticosteroids)IBA 02/2022
1	Programmed Cell Death 1 ReceptorIBA 02/2022
1	sonidegibIBA 01/2022
1	Acitretin FDA Link 06/2019
1	Complement System Proteins (Complement)IBA 02/2019
1	Cholecalciferol (Vitamin D3)FDA Link 12/2018
1	Zoledronic Acid (Zometa)FDA Link 12/2018
1	CalciumIBA 12/2018
1	durvalumabIBA 01/2018
1	pembrolizumabIBA 01/2018
1	AntibodiesIBA 01/2018
1	Creatine Kinase (Creatine Phosphokinase)IBA 01/2018
1	Cholinergic ReceptorsIBA 01/2018
1	Adrenocorticotropic Hormone (ACTH)FDA Link 12/2017
1	Hydrocortisone (Cortisol)FDA LinkGeneric 12/2017
1	cobimetinibIBA 10/2017
1	VemurafenibIBA 10/2017
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 10/2017
1	Vinblastine (Vinblastine Sulfate)FDA Link 09/2015